1. Home
  2. Analysis
  3. Ribapak
  4. Amlodipine-besylate

Ribapak and Amlodipine besylate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribapak (ribavirin) and Amlodipine besylate (amlodipine besylate). Common drug interactions include fatigue among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Ribapak and Amlodipine besylate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ribapak?

Ribapak has active ingredients of ribavirin. eHealthMe is studying from 3,392 Ribapak users. Check the latest studies of Ribapak.

What is Amlodipine besylate?

Amlodipine besylate has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 75,293 Amlodipine besylate users. Check the latest studies of Amlodipine besylate.

On Jul, 11, 2026

13 people who take Ribapak and Amlodipine besylate together, and have interactions are studied.

Ribapak and Amlodipine besylate drug interactions.

What are the common drug interactions of Ribapak and Amlodipine Besylate, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Pruritus (severe itching of the skin)
  3. Rash
  4. Drug ineffective
  5. Anal pruritus (anal itching)
  6. Asthenia (weakness)
  7. Flushing (the warm, red condition of human skin)
  8. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  9. Headache (pain in head)
  10. Influenza like illness

male:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Hypotension (abnormally low blood pressure)
  4. Impatience (restlessness)
  5. Insomnia (sleeplessness)
  6. Irritability
  7. Lethargy (tiredness)
  8. Mood altered (changes in mood)
  9. Mood swings (an extreme or rapid change in mood)
  10. Nasopharyngitis (inflammation of the nasopharynx)

What are the common drug interactions of Ribapak and Amlodipine Besylate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Flushing (the warm, red condition of human skin)
  2. Headache (pain in head)
  3. Influenza like illness
  4. Injection site erythema (redness at injection site)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Pruritus (severe itching of the skin)
  3. Anal pruritus (anal itching)
  4. Diarrhoea
  5. Dizziness
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  7. Headache (pain in head)
  8. Hypotension (abnormally low blood pressure)
  9. Rash
  10. Vomiting

60+:

  1. Fatigue (feeling of tiredness)
  2. Alopecia (absence of hair from areas of the body)
  3. Mood swings (an extreme or rapid change in mood)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Oropharyngeal pain
  6. Pruritus (severe itching of the skin)
  7. Pulmonary congestion (congestion in the lungs)
  8. Rash
  9. Anorectal discomfort
  10. Anxiety

What are the existing conditions these people have? *

  1. Hepatitis C: 11 people, 84.62%

* Approximation only. Some reports may have incomplete information.

Do you take Ribapak and Amlodipine besylate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribapak and Amlodipine besylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribapak:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amlodipine besylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribapak and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amlodipine besylate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and amlodipine besylate (the active ingredients of Ribapak and Amlodipine besylate, respectively), and Ribapak and Amlodipine besylate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.